Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Stimulator of interferon genes (STING)-TANK-binding kinase 1 (TBK1) protein-protein interaction complex is a central component of the cGAS-STING signaling pathway, which is essential for the innate immune detection of cytosolic DNA (PubMed: 31439605). Upon binding of cyclic GMP-AMP (cGAMP), STING translocates from the endoplasmic reticulum to the Golgi apparatus, where it recruits TBK1 via its C-terminal tail (CTT) (PubMed: 30842659). This interaction facilitates the trans-autophosphorylation of TBK1 and the subsequent phosphorylation of STING and the transcription factor IRF3. The resulting signaling cascade induces the expression of type I interferons and other pro-inflammatory cytokines necessary for host defense against pathogens. Chronic or constitutive activation of this complex is a primary driver of autoinflammatory diseases, including STING-associated vasculopathy with onset in infancy (SAVI) and systemic lupus erythematosus (PubMed: 25099571). Consequently, small molecules designed to disrupt the STING-TBK1 interaction or inhibit TBK1 kinase activity within the complex are being developed as therapeutic agents for autoimmune and inflammatory conditions. Conversely, STING agonists that promote this interaction are being investigated in oncology to stimulate anti-tumor immunity (PubMed: 31941639).
Modulation of the STING-TBK1 complex through either direct inhibition of the STING-TBK1 protein-protein interaction, inhibition of TBK1 kinase activity, or agonistic/antagonistic binding to the STING protein to alter complex formation and downstream signaling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stimulator of interferon genes (STING)-TANK-binding kinase 1 (TBK1) protein-protein interaction complex (STING-TBK1 complex).